Patent details

EP3226887 Title: ACTRIIB POLYPEPTIDES FOR USE IN THE TREATMENT SIDEROBLASTIC ANEMIA

Basic Information

Publication number:
EP3226887
PCT Application Number:
US2015063835
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP158651034
PCT Publication Number:
WO2016090188
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ACTRIIB POLYPEPTIDES FOR USE IN THE TREATMENT SIDEROBLASTIC ANEMIA
French Title of Invention:
ACTRIIB POLYPETIDES POUR UTILISATION DANS LE TRAITEMENT D'ANÉMIE SIDÉROBLASTIQUE
German Title of Invention:
ACTRIIB POLYPEPTIDE ZUR VERWENDUNG IN DER BEHANDLUNG VON SIDEROBLASTISCHER ANÄMIE
SPC Number:

Dates

Filing date:
03/12/2015
Grant date:
27/03/2024
EP Publication Date:
11/10/2017
PCT Publication Date:
09/06/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/03/2024
EP B1 Publication Date:
27/03/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/12/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/03/2024
 
 

Name:
Acceleron Pharma Inc.
Address:
128 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:
ROVALDI, Christopher, Robert
Address:
United States (US)

2

Name:
ATTIE, Kenneth, M.
Address:
United States (US)

Priority

1

Priority Number:
201462086977 P
Priority Date:
03/12/2014
Priority Country:
United States (US)

2

Priority Number:
201462088087 P
Priority Date:
05/12/2014
Priority Country:
United States (US)

3

Priority Number:
201562155395 P
Priority Date:
30/04/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 35/18; A61K 38/18; A61K 35/14; A61K 38/17; A61K 39/395; C07K 14/495; C07K 14/71; C12Q 1/6883; A61P 7/00; A61P 7/06; A61P 35/02; A61P 43/00;

Publication

European Patent Bulletin

1

Issue number:
202413
Publication date:
27/03/2024
Description:
Grant (B1)

2

Issue number:
202505
Publication date:
29/01/2025
Description:
Opposition procedure started

Annual Fees

Annual Fee Due Date:
30/06/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages